Condition

Hepatorenal Syndrome clinical trials and research

As of November 12, 2026, Find a Trial lists 4 Hepatorenal Syndrome clinical trials that are recruiting, at sites in 3 countries (most in United States (2), Germany (1), Hong Kong (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Hepatorenal Syndrome clinical trials

StudyPhaseWhereStatusRegistered
Evaluating fluid treatment strategies for kidney injury in cirrhosis patients — Boston, Massachusetts Recruiting Jul 29, 2024
Analysis of outcomes in patients with Hepatorenal Syndrome — Dallas, Texas Recruiting Oct 23, 2023
TIPS treatment for patients with cirrhosis and acute kidney injury — Aachen and 13 other locations Recruiting Apr 26, 2022
Predicting hepatorenal syndrome in cirrhotic patients using biomarkers — Hong Kong Recruiting May 5, 2015

All recruiting trials (4)

Related topics

Acute Kidney InjuryCirrhosis, LiverAscites Hepatic

Quick answers

How many Hepatorenal Syndrome clinical trials are recruiting right now?

4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in United States (2 trials), Germany (1 trial), Hong Kong (1 trial). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.